Showing results (351-360 of 389) with videos related to

Sort By:
Pageof 39
Emerging Infectious Diseases|May 8, 2007
Pneumocystis pneumonia in HIV-positive adults, MalawiJoep J G van Oosterhout, Miriam K Laufer, M Arantza Perez, et al.
Plos Neglected Tropical Diseases|December 8, 2017
Presentation of life-threatening invasive nontyphoidal Salmonella disease in Malawian children: A prospective observational studyCalman A MacLennan, Chisomo L Msefula, Esther N Gondwe, et al.
The New England Journal of Medicine|December 18, 2024
Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in VietnamGreg J Fox, Nguyen Viet Nhung, Nguyen Cam Binh, et al.
BMJ Global Health|October 7, 2021
Standardised patient study to assess tuberculosis case detection within the private pharmacy sector in VietnamShukry Zawahir, Hien Le, Thu Anh Nguyen, et al.
The New England Journal of Medicine|October 3, 2019
Community-wide Screening for Tuberculosis in a High-Prevalence SettingGuy B Marks, Nhung V Nguyen, Phuong T B Nguyen, et al.
The Lancet. Global Health|November 2, 2023
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trialMaryline Bonnet, Anca Vasiliu, Boris K Tchounga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An UpdateStephen M Graham, Luis E Cuevas, Patrick Jean-Philippe, et al.
Lancet (London, England)|May 22, 2010
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to actionBen J Marais, Mario C Raviglione, Peter R Donald, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2025
Emerging evidence to reduce the burden of tuberculosis in children and young peopleJulie Huynh, Yara-Natalie Abo, Rina Triasih, et al.
The New England Journal of Medicine|August 2, 2018
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in AdultsDick Menzies, Menonli Adjobimey, Rovina Ruslami, et al.
Pageof 39